Regen BioPharma Inc (RGBP)

[art35]

OTCShotCaller
7/17/22, 08:30 PM
This is WHY I've previously said Koos needs a $ Billion Dollars to move ALL his active IP through all Phases of Clinical Trials. Is it making sense now as to WHY he needs a Big Pharma B/O or M/A??!! The current IND alone for his mRNA Cancer Vaccine for all 4 Phases of Clinical Trials is going to cost somewhere in the range between $80M to $160M depending on multiple factors, and this is only a rough estimate due to their being a myriad of variables.

Personally I believe it's going to cost close to $100M for his current IND alone which is a conservative estimate! Rock bottom $80M
but unlikely. The same applies to his other active IP that have not yet advanced into an FDA IND submission. The man needs very serious LONG TERM cash capital requirements and the ONLY foreseeable way that's going to happen is via a B/O or M/A, again, not only for his current IND but his several others. I discern this is WHY we haven't heard from him in some time likely due to him being in B/O negotiations.